Synthesis and biological evaluation of triazole based uracil derivatives as novel DPP-4 inhibitors.

about

Synthesis and biological evaluation of triazole based uracil derivatives as novel DPP-4 inhibitors.

Item

http://www.wikidata.org/entity/Q38813948

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Synthesis and biological evalu ...... ves as novel DPP-4 inhibitors.

@en

type

Item

label

Synthesis and biological evalu ...... ves as novel DPP-4 inhibitors.

@en

prefLabel

Synthesis and biological evalu ...... ves as novel DPP-4 inhibitors.

@en

P1476

Synthesis and biological evalu ...... ves as novel DPP-4 inhibitors.

@en

P2093

Bin Zhang

http://www.w3.org/2001/XMLSchema#string

Huibin Zhang

http://www.w3.org/2001/XMLSchema#string

Jinpei Zhou

http://www.w3.org/2001/XMLSchema#string

Li Han

http://www.w3.org/2001/XMLSchema#string

Qing Li

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV

8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes

Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV

Discovery of a 3-pyridylacetic acid derivative (TAK-100) as a potent, selective and orally active dipeptidyl peptidase IV (DPP-4) inhibitor

A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site

Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Biology of incretins: GLP-1 and GIP

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.

P304

9598-9611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C6OB01818A

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27714283

http://www.w3.org/2001/XMLSchema#string